These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16028772

  • 1. Assessment of cerebral S100B levels by proton magnetic resonance spectroscopy after lateral fluid-percussion injury in the rat.
    Kleindienst A, Tolias CM, Corwin FD, Müller C, Marmarou A, Fatouros P, Bullock MR.
    J Neurosurg; 2005 Jun; 102(6):1115-21. PubMed ID: 16028772
    [Abstract] [Full Text] [Related]

  • 2. Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat.
    Kleindienst A, Harvey HB, Rice AC, Müller C, Hamm RJ, Gaab MR, Bullock MR.
    J Neurotrauma; 2004 May; 21(5):541-7. PubMed ID: 15165362
    [Abstract] [Full Text] [Related]

  • 3. Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury.
    Kleindienst A, McGinn MJ, Harvey HB, Colello RJ, Hamm RJ, Bullock MR.
    J Neurotrauma; 2005 Jun; 22(6):645-55. PubMed ID: 15941374
    [Abstract] [Full Text] [Related]

  • 4. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.
    Kleindienst A, Meissner S, Eyupoglu IY, Parsch H, Schmidt C, Buchfelder M.
    Acta Neurochir Suppl; 2010 Jun; 106():247-50. PubMed ID: 19812958
    [Abstract] [Full Text] [Related]

  • 5. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
    Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H.
    J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
    [Abstract] [Full Text] [Related]

  • 6. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.
    Rainey T, Lesko M, Sacho R, Lecky F, Childs C.
    Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161
    [Abstract] [Full Text] [Related]

  • 7. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults.
    Rodríguez-Rodríguez A, Egea-Guerrero JJ, León-Justel A, Gordillo-Escobar E, Revuelto-Rey J, Vilches-Arenas A, Carrillo-Vico A, Domínguez-Roldán JM, Murillo-Cabezas F, Guerrero JM.
    Clin Chim Acta; 2012 Dec 24; 414():228-33. PubMed ID: 23031665
    [Abstract] [Full Text] [Related]

  • 8. Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury.
    Hendoui N, Beigmohammadi MT, Mahmoodpoor A, Ahmadi A, Abdollahi M, Hasanpour M, Hadi F, Khazaeipour Z, Mousavi S, Mojtahedzadeh M.
    Eur Rev Med Pharmacol Sci; 2013 Feb 24; 17(4):477-85. PubMed ID: 23467946
    [Abstract] [Full Text] [Related]

  • 9. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RS, Ruppel RA, Kochanek PM.
    Pediatrics; 2002 Feb 24; 109(2):E31. PubMed ID: 11826241
    [Abstract] [Full Text] [Related]

  • 10. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.
    Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.
    Clin Lab; 2011 Feb 24; 57(7-8):587-97. PubMed ID: 21888023
    [Abstract] [Full Text] [Related]

  • 11. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
    Baker AJ, Rhind SG, Morrison LJ, Black S, Crnko NT, Shek PN, Rizoli SB.
    J Neurotrauma; 2009 Aug 24; 26(8):1227-40. PubMed ID: 19637968
    [Abstract] [Full Text] [Related]

  • 12. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury.
    Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, Rhind S, Tien HC, Baker AJ.
    J Trauma; 2011 Nov 24; 71(5 Suppl 1):S478-86. PubMed ID: 22072007
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
    Geyer C, Ulrich A, Gräfe G, Stach B, Till H.
    J Neurosurg Pediatr; 2009 Oct 24; 4(4):339-44. PubMed ID: 19795965
    [Abstract] [Full Text] [Related]

  • 14. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.
    da Rocha AB, Schneider RF, de Freitas GR, André C, Grivicich I, Zanoni C, Fossá A, Gehrke JT, Pereira Jotz G, Kaufmann M, Simon D, Regner A.
    Clin Chem Lab Med; 2006 Oct 24; 44(10):1234-42. PubMed ID: 17032136
    [Abstract] [Full Text] [Related]

  • 15. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
    Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM.
    J Neurosurg; 2005 Jul 24; 103(1 Suppl):61-8. PubMed ID: 16122007
    [Abstract] [Full Text] [Related]

  • 16. GFAP and S100B in the acute phase of mild traumatic brain injury.
    Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J.
    Neurology; 2012 May 01; 78(18):1428-33. PubMed ID: 22517109
    [Abstract] [Full Text] [Related]

  • 17. [S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children].
    Sorokina EG, Semenova ZhB, Granstrem OK, Karaseva OV, Meshcheriakov SV, Reutov VP, Sushkevich GN, Pinelis VG, Roshal' LM.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 May 01; 110(8):30-5. PubMed ID: 20823827
    [Abstract] [Full Text] [Related]

  • 18. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, Stöcklein V, Bazarian JJ.
    J Neurotrauma; 2009 Sep 01; 26(9):1497-1507. PubMed ID: 19257803
    [Abstract] [Full Text] [Related]

  • 19. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury.
    Cai XY, Lu L, Wang YN, Jin C, Zhang RY, Zhang Q, Chen QJ, Shen WF.
    Atherosclerosis; 2011 Aug 01; 217(2):536-42. PubMed ID: 21663912
    [Abstract] [Full Text] [Related]

  • 20. Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.
    Filippidis AS, Papadopoulos DC, Kapsalaki EZ, Fountas KN.
    Neurosurg Focus; 2010 Nov 01; 29(5):E2. PubMed ID: 21039136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.